Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Treatment options for bipolar mania].

T Attarbaschi1, S Kasper

  • 1Klinische Abteilung für Allgemeine Psychiatrie, Medizinische Universität Wien, Währinger Gürtel 18-20, 1090 Wien, Osterreich. trawat.attarbaschi@meduniwien.ac.at

Der Nervenarzt
|June 15, 2006
PubMed
Summary

Atypical antipsychotics are increasingly preferred for treating bipolar mania due to the side effects of older medications. This review surveys data on atypical antipsychotics for mania treatment and discusses agent selection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fruquintinib in combination with tislelizumab versus trifluridine/tipiracil and bevacizumab in third-line and beyond MSS mCRC without active liver metastases-the IKF-080/AIO-QUINTIS trial.

ESMO gastrointestinal oncology·2026
Same author

Virtual reality support during systemic cancer therapy to improve anxiety/depressive symptoms and reduce toxicity in patients with gastrointestinal cancers-OncoVR.

ESMO gastrointestinal oncology·2026
Same author

TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.

ESMO gastrointestinal oncology·2026
Same author

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.

ESMO gastrointestinal oncology·2026
Same author

Human <i>in vivo</i> assessment of ketamine binding of the serotonin transporter-follow up at a higher dose.

Frontiers in neuroscience·2025
Same author

Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.

ESMO open·2025

Area of Science:

  • Psychiatry
  • Pharmacology

Context:

  • Bipolar mania presents significant diagnostic and therapeutic challenges.
  • Traditional treatments like lithium and divalproex have limitations.
  • Typical neuroleptics, while effective, cause significant side effects, particularly extrapyramidal symptoms.

Purpose:

  • To review controlled study data on atypical antipsychotics for bipolar mania.
  • To discuss the selection criteria for appropriate atypical antipsychotic agents.

Summary:

  • Atypical antipsychotics are emerging as a preferred treatment for bipolar mania.
  • This review examines efficacy data from controlled studies of various atypical antipsychotics.
  • Key considerations for choosing the optimal atypical agent are discussed.

Impact:

  • Provides clinicians with an updated overview of atypical antipsychotic options for bipolar mania.
  • Aids in informed decision-making for selecting the most suitable atypical agent based on efficacy and side effect profiles.
  • Contributes to improved management strategies for bipolar mania.

Related Experiment Videos